Physician profile
Kathryn E Griffith
NPI 1952691560
$1,089.82
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $640 · 2022: $450.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $211.96 | 2021-2022 | |
| Abbvie INC. | $205.64 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $176.98 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $104.43 | 2021 | |
| Alkermes, INC. | $90.46 | 2022 | |
| Sunovion Pharmaceuticals INC. | $66.60 | 2021 | |
| Adlon Therapeutics L.P. | $41.93 | 2021 | |
| Corium, LLC | $41.57 | 2022 | |
| Supernus Pharmaceuticals, INC. | $36.90 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $19.00 | 2021 | |
| Neurocrine Biosciences, INC. | $18.94 | 2022 | |
| Ironshore Pharmaceuticals INC. | $16.82 | 2021 | |
| Tris Pharma INC | $15.25 | 2021 | |
| Lundbeck LLC | $15.23 | 2021 | |
| Eisai INC. | $14.75 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $13.36 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.